Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Computer Resources
      • Highly Cited Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Early Career Award
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citations
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Research
Cancer Research
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Computer Resources
      • Highly Cited Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Early Career Award
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citations
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Advances in Brief

Characterization of the Human Rad51 Genomic Locus and Examination of Tumors with 15q14–15 Loss of Heterozygosity (LOH)

Christoph Schmutte, Gregory Tombline, Kerstin Rhiem, Margaret M. Sadoff, Rita Schmutzler, Andreas von Deimling and Richard Fishel
Christoph Schmutte
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gregory Tombline
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kerstin Rhiem
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Margaret M. Sadoff
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rita Schmutzler
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andreas von Deimling
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Richard Fishel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI:  Published September 1999
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Fig. 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 1.

    Radiation hybrid analysis. The hRAD51 genomic locus, CYP19, and several additional microsatellite markers were mapped to chromosome 15q14–15 using the radiation hybrid method (see “Materials and Methods” for details). Markers used in LOH studies are underlined.

  • Fig. 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 2.

    hRad51 genomic structure. A human BAC clone containing the hRad51 gene was identified by screening a BAC library (Research Genetics). Exon-intron borders were determined by direct sequencing of the BAC DNA. A, hRad51 consists of 10 exons (dark gray box, coding exons; light gray box, noncoding exons) and covers ∼30 kb (*, introns sequenced completely). B, exon-intron borders follow the GT-AG rule. Capital letters, intronic sequences. Numbers in parentheses, size (in bp) of the published cDNA sequence (GenBank accession number D14134).

  • Fig. 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 3.

    Analysis of the CpG island in the 5′ region of the hRad51 gene. The 5′ region of the hRad51 gene was sequenced and analyzed using the GCG Software Package (GCG, Madison, WI). The translation start site (ATG) was used as 0. According to the rules established by Gardiner-Garden and Frommer (43) , a region of 989 bp can be considered a CpG island (▪), which covers exon 1 (□) and extends into intron 1. The region marked by the Embedded Image was examined for changes in DNA methylation.

Tables

  • Figures
  • Table 1

    Primers used for mutational analysis

    Exon 2
     CAAGCCCCTTATTTCTCTAGTR37; 5′
     CCTTCCACTAGGTAGAAGAAR38; 3′
    Exon 3
     GGACACATAACATCTGTGTTAGR39; 5′
     TGTACTATTCCCACTAATGCCTR40; 3′
    Exon 4
     TCAAGATCACTGTGGTAAGGAR41; 5′
     GCTTTCCTAACTAGAGTTCACR42; 3′
    Exon 5
     CCAAGAACATTTCTATGACTACAGR43; 5′
     CAGGAATGAAGTAATGCTTGCR44; 3′
    Exon 6
     CTTGGTCAGCTGTATCAGAAATR45; 5′
     GATAAGTGTAGCCATAGTCTCTR45; 3′
    Exon 7
     AGTTCTGTGTGCAGCCTAAAR47; 5′
     GGGAAGGACTCTTAAGAACATR48; 3′
    Exon 8
     ACAGGCTAGAAATAGGCTTCAR49; 5′
     CTGAAAGTAGGCATTCTCTGTR50; 3′
    Exon 9
     GTCTATGGCCACAAAATTGACAR51; 5′
     TCCGAAAAGAAGAACTGATCCR52; 3′
    Exon 10
     CAAAGTCAGGAACGGAATTGTR53; 5′
     R54; 3′
  • Table 2
PreviousNext
Back to top
September 1999
Volume 59, Issue 18
  • Table of Contents

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Characterization of the Human Rad51 Genomic Locus and Examination of Tumors with 15q14–15 Loss of Heterozygosity (LOH)
(Your Name) has forwarded a page to you from Cancer Research
(Your Name) thought you would be interested in this article in Cancer Research.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Characterization of the Human Rad51 Genomic Locus and Examination of Tumors with 15q14–15 Loss of Heterozygosity (LOH)
Christoph Schmutte, Gregory Tombline, Kerstin Rhiem, Margaret M. Sadoff, Rita Schmutzler, Andreas von Deimling and Richard Fishel
Cancer Res September 15 1999 (59) (18) 4564-4569;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Characterization of the Human Rad51 Genomic Locus and Examination of Tumors with 15q14–15 Loss of Heterozygosity (LOH)
Christoph Schmutte, Gregory Tombline, Kerstin Rhiem, Margaret M. Sadoff, Rita Schmutzler, Andreas von Deimling and Richard Fishel
Cancer Res September 15 1999 (59) (18) 4564-4569;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • Activating Mutations of the Noonan Syndrome-Associated SHP2/PTPN11 Gene in Human Solid Tumors and Adult Acute Myelogenous Leukemia
  • 2-Arachidonoylglycerol
  • Recombinant Listeria Vaccines Containing PEST Sequences Are Potent Immune Adjuvants for the Tumor-Associated Antigen Human Papillomavirus-16 E7
Show more Advances in Brief
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Research Online ISSN: 1538-7445
Cancer Research Print ISSN: 0008-5472
Journal of Cancer Research ISSN: 0099-7013
American Journal of Cancer ISSN: 0099-7374

Advertisement